JP2022525482A - 胃内滞留剤形用のコーティング - Google Patents

胃内滞留剤形用のコーティング Download PDF

Info

Publication number
JP2022525482A
JP2022525482A JP2021556624A JP2021556624A JP2022525482A JP 2022525482 A JP2022525482 A JP 2022525482A JP 2021556624 A JP2021556624 A JP 2021556624A JP 2021556624 A JP2021556624 A JP 2021556624A JP 2022525482 A JP2022525482 A JP 2022525482A
Authority
JP
Japan
Prior art keywords
gastric retention
coating
enlobed
treated
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021556624A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022525482A5 (enExample
Inventor
カナスティー ローズマリー
グラント タイラー
ピーク エリック
ビース ヌプラ
オルトルーター デイビッド
ホラー ソニア
シュワルツ マーリーン
Original Assignee
リンドラ セラピューティクス， インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by リンドラ セラピューティクス， インコーポレイティド filed Critical リンドラ セラピューティクス， インコーポレイティド
Publication of JP2022525482A publication Critical patent/JP2022525482A/ja
Publication of JP2022525482A5 publication Critical patent/JP2022525482A5/ja
Priority to JP2025006073A priority Critical patent/JP2025067914A/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/005—Coating of tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
JP2021556624A 2019-03-20 2020-03-19 胃内滞留剤形用のコーティング Withdrawn JP2022525482A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025006073A JP2025067914A (ja) 2019-03-20 2025-01-16 胃内滞留剤形用のコーティング

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962821361P 2019-03-20 2019-03-20
US62/821,361 2019-03-20
PCT/US2020/023710 WO2020191231A1 (en) 2019-03-20 2020-03-19 Coatings for gastric residence dosage forms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025006073A Division JP2025067914A (ja) 2019-03-20 2025-01-16 胃内滞留剤形用のコーティング

Publications (2)

Publication Number Publication Date
JP2022525482A true JP2022525482A (ja) 2022-05-16
JP2022525482A5 JP2022525482A5 (enExample) 2024-08-07

Family

ID=72519158

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021556624A Withdrawn JP2022525482A (ja) 2019-03-20 2020-03-19 胃内滞留剤形用のコーティング
JP2025006073A Pending JP2025067914A (ja) 2019-03-20 2025-01-16 胃内滞留剤形用のコーティング

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025006073A Pending JP2025067914A (ja) 2019-03-20 2025-01-16 胃内滞留剤形用のコーティング

Country Status (10)

Country Link
US (1) US12582608B2 (enExample)
EP (1) EP3941444B1 (enExample)
JP (2) JP2022525482A (enExample)
CN (1) CN113840596A (enExample)
AU (1) AU2020242062B2 (enExample)
BR (1) BR112021018424A2 (enExample)
CA (1) CA3134186A1 (enExample)
IL (1) IL286510A (enExample)
MX (1) MX2021011310A (enExample)
WO (1) WO2020191231A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024225479A1 (ja) * 2023-04-28 2024-10-31 クオリカプス株式会社 バンドシール液、バンドシール、ゼラチン硬質カプセルの封緘方法、及びゼラチン硬質カプセル製品

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020117855A1 (en) 2018-12-03 2020-06-11 Lyndra, Inc. Stomach simulating device
BR112021018496A2 (pt) 2019-03-20 2021-11-30 Lyndra Therapeutics Inc Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica
AU2020242062B2 (en) 2019-03-20 2025-12-11 Nortiva Bio, Inc. Coatings for gastric residence dosage forms
JP7847119B2 (ja) 2020-07-29 2026-04-16 ザ・セカント・グループ・エルエルシー 架橋ポリ（セバシン酸グリセロール）を含む構造を含む形状誘導型制御放出および保持

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006508021A (ja) * 2002-03-26 2006-03-09 ユーロ−セルティーク エス．エイ． 徐放性ゲルコーティング組成物
JP2007145756A (ja) * 2005-11-28 2007-06-14 Morishita Jintan Kk 胃内浮遊滞留シームレスカプセルとその製造方法
JP2009523175A (ja) * 2006-01-10 2009-06-18 パイペックス，インコーポレイテッド 目標とされる安定な銅状態を達成及び維持して銅関連中枢神経系疾患を予防及び治療するための医薬組成物及び方法
WO2011048494A2 (en) * 2009-10-19 2011-04-28 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
JP2012500230A (ja) * 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
JP2012510987A (ja) * 2008-12-04 2012-05-17 インテック ファーマ リミテッド ザレプロン胃内滞留性薬剤送達システム
JP2013129669A (ja) * 2006-01-18 2013-07-04 Intec Pharma Ltd 胃滞留性経口薬剤送達デバイス
WO2017022248A1 (ja) * 2015-08-04 2017-02-09 富士カプセル株式会社 腸溶性カプセル
JP2017518308A (ja) * 2014-06-02 2017-07-06 テバ ファーマシューティカル インダストリーズ リミティド 膨張性胃内滞留型剤形
JP2017524662A (ja) * 2014-06-11 2017-08-31 マサチューセッツ インスティテュート オブ テクノロジー 滞留構造体および関連方法
WO2018102799A1 (en) * 2016-12-02 2018-06-07 Clexio Biosciences Ltd. Gastric residence system
JP2018517735A (ja) * 2015-06-17 2018-07-05 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． フマル酸ジメチル粒子及びそれらの医薬組成物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706149D0 (en) * 1997-03-25 1997-05-14 Scherer Corp R P Comestible capsules having flavoured coatings
WO2003051304A2 (en) 2001-12-15 2003-06-26 Spherics, Inc. Bioadhesive drug delivery system with enhanced gastric retention
IL166183A0 (en) 2005-01-06 2006-01-15 Yissum Res Dev Co Novel diagnostic and imaging techniques of the gi tract
KR20080005429A (ko) * 2005-04-19 2008-01-11 알자 코포레이션 트라마돌 및 가바펜틴을 포함하는 물질의 배합물
WO2007002518A1 (en) 2005-06-23 2007-01-04 Spherics, Inc. Delayed release or extended-delayed release dosage forms of pramipexole
WO2007093999A1 (en) * 2006-02-15 2007-08-23 Intec Pharma Ltd. A gastro-retentive system for the delivery of macromolecules
US8006033B2 (en) 2008-09-09 2011-08-23 Intel Corporation Systems, methods, and apparatuses for in-band data mask bit transmission
US8414559B2 (en) 2009-05-07 2013-04-09 Rainbow Medical Ltd. Gastroretentive duodenal pill
CA2825917C (en) 2011-02-14 2016-08-30 The Procter & Gamble Company Filmcoated solid dosage forms comprising honey in the coating
WO2014035639A1 (en) 2012-08-29 2014-03-06 Cardiac Pacemakers, Inc. Enhanced low friction coating for medical leads and methods of making
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
WO2015195989A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
EP3288604B1 (en) 2015-05-01 2021-11-17 Massachusetts Institute of Technology Triggerable shape memory induction devices
US11576859B2 (en) 2015-10-23 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
WO2017100367A1 (en) 2015-12-08 2017-06-15 Lyndra, Inc. Geometric configurations for gastric residence systems
CN109310639A (zh) 2016-05-27 2019-02-05 林德拉有限公司 用于胃驻留系统的材料结构
JP2019532947A (ja) 2016-09-30 2019-11-14 リンドラ，インコーポレイティド アダマンタン系薬物の持続的送達のための胃内滞留システム
CA3066658A1 (en) 2017-06-09 2018-12-13 Lyndra, Inc. Gastric residence systems with release rate-modulating films
US11793751B2 (en) 2017-09-20 2023-10-24 Lyndra Therapeutics, Inc. Encapsulation of gastric residence systems
JP2021535090A (ja) 2018-08-15 2021-12-16 リンドラ セラピューティクス， インコーポレイティド 治療薬物の腸内送達のためのシステム
WO2020117855A1 (en) 2018-12-03 2020-06-11 Lyndra, Inc. Stomach simulating device
AU2020242062B2 (en) 2019-03-20 2025-12-11 Nortiva Bio, Inc. Coatings for gastric residence dosage forms
BR112021018496A2 (pt) 2019-03-20 2021-11-30 Lyndra Therapeutics Inc Cápsulas e revestimento de cápsula para formas de dosagem de residência gástrica
WO2021092486A1 (en) 2019-11-08 2021-05-14 Lyndra, Inc. Formulations for release-rate modulating films for gastric residence systems
IL292848A (en) 2019-11-08 2022-07-01 Lyndra Therapeutics Inc Polymeric linkers for a gastric residence system
JP2022553867A (ja) 2019-11-08 2022-12-26 リンドラ セラピューティクス， インコーポレイティド 胃内滞留を改善するフィラメントを有する胃内滞留システム
MX2022005494A (es) 2019-11-08 2022-08-11 Lyndra Therapeutics Inc Sistemas de residencia gastrica para la administracion de agentes activos.
US20220387312A1 (en) 2019-11-08 2022-12-08 Lyndra Therapeutics, Inc. Gastric residence systems having arms with controlled stiffness for improved gastric residence
US20240390270A1 (en) 2021-01-19 2024-11-28 Lyndra Therapeutics, Inc. Gastric residence systems for administration of risperidone
JP2024517829A (ja) 2021-05-05 2024-04-23 リンドラ セラピューティクス， インコーポレイティド メタドンを含む胃内滞留システム
WO2022236288A1 (en) 2021-05-05 2022-11-10 Lyndra Therapeutics, Inc. Gastric residence systems comprising buprenorphine and naloxone
AU2023209872A1 (en) 2022-01-19 2024-08-01 Nortiva Bio, Inc. Dosage forms for gastric retention
CN120091832A (zh) 2022-08-03 2025-06-03 林德拉治疗公司 用于胃驻留系统的金属芯部
JP2025531626A (ja) 2022-09-30 2025-09-22 リンドラ セラピューティクス， インコーポレイティド 胃内滞留システムを用いたリスペリドンの投与レジメン
US20240398701A1 (en) 2023-06-02 2024-12-05 Lyndra Therapeutics, Inc. Manufacturing methods for gastric residence systems

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006508021A (ja) * 2002-03-26 2006-03-09 ユーロ−セルティーク エス．エイ． 徐放性ゲルコーティング組成物
JP2007145756A (ja) * 2005-11-28 2007-06-14 Morishita Jintan Kk 胃内浮遊滞留シームレスカプセルとその製造方法
JP2009523175A (ja) * 2006-01-10 2009-06-18 パイペックス，インコーポレイテッド 目標とされる安定な銅状態を達成及び維持して銅関連中枢神経系疾患を予防及び治療するための医薬組成物及び方法
JP2013129669A (ja) * 2006-01-18 2013-07-04 Intec Pharma Ltd 胃滞留性経口薬剤送達デバイス
JP2012500230A (ja) * 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
JP2012510987A (ja) * 2008-12-04 2012-05-17 インテック ファーマ リミテッド ザレプロン胃内滞留性薬剤送達システム
WO2011048494A2 (en) * 2009-10-19 2011-04-28 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
JP2017518308A (ja) * 2014-06-02 2017-07-06 テバ ファーマシューティカル インダストリーズ リミティド 膨張性胃内滞留型剤形
JP2017524662A (ja) * 2014-06-11 2017-08-31 マサチューセッツ インスティテュート オブ テクノロジー 滞留構造体および関連方法
JP2018517735A (ja) * 2015-06-17 2018-07-05 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． フマル酸ジメチル粒子及びそれらの医薬組成物
WO2017022248A1 (ja) * 2015-08-04 2017-02-09 富士カプセル株式会社 腸溶性カプセル
WO2018102799A1 (en) * 2016-12-02 2018-06-07 Clexio Biosciences Ltd. Gastric residence system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024225479A1 (ja) * 2023-04-28 2024-10-31 クオリカプス株式会社 バンドシール液、バンドシール、ゼラチン硬質カプセルの封緘方法、及びゼラチン硬質カプセル製品

Also Published As

Publication number Publication date
EP3941444A1 (en) 2022-01-26
CA3134186A1 (en) 2020-09-24
IL286510A (en) 2021-10-31
CN113840596A (zh) 2021-12-24
MX2021011310A (es) 2021-12-10
AU2020242062B2 (en) 2025-12-11
US20220192995A1 (en) 2022-06-23
BR112021018424A2 (pt) 2021-11-23
JP2025067914A (ja) 2025-04-24
EP3941444B1 (en) 2025-03-26
US12582608B2 (en) 2026-03-24
WO2020191231A1 (en) 2020-09-24
AU2020242062A1 (en) 2021-11-11
EP3941444A4 (en) 2023-01-11

Similar Documents

Publication Publication Date Title
JP2022525482A (ja) 胃内滞留剤形用のコーティング
JP2022525482A5 (enExample)
JP2022525926A (ja) 胃内滞留剤形用のカプセル及びカプセルコーティング
JP5513113B2 (ja) 弱塩基性薬剤の固溶体を含む薬剤送達システム
JP2022525926A5 (enExample)
US20120301546A1 (en) Acid-resistant soft gel compositions
RU2375048C2 (ru) Фармацевтическая композиция с набухающим покрытием
TWI543780B (zh) 雙叉乳酸桿菌大腸遞送膠囊及其製造方法
US20190000768A1 (en) Enteric capsule
US20140314846A1 (en) Multiple unit pharmaceutical formulation
BG104634A (bg) Микрогранули от омепразол със стомашно защитно действие, метод за тяхното получаване и фармацевтични препарати
KR20060065632A (ko) 팽창성 코팅을 갖는 약제학적 조성물
CA3003644A1 (en) Extended release film-coated capsules
CN101903017B (zh) 具有增强的脉冲活性物质释放的包衣的药物或营养制剂
US20050147663A1 (en) Method of treatment for improved bioavailability
CN103402501A (zh) 调节释放的苯并咪唑制剂
CN101820866A (zh) 用于固体剂型的机械保护层
JP7719609B2 (ja) 腸溶性硬質カプセル
HK40066247B (en) Coatings for gastric residence dosage forms
HK40066247A (en) Coatings for gastric residence dosage forms
TR2023003089T2 (tr) Mesalami̇n ve i̇lgi̇li̇ eksi̇pi̇yanlari i̇çeren farmasöti̇k kompozi̇syonlar
CN1835738A (zh) 具有可膨胀的包衣的药物组合物
WO2022066110A1 (en) Pharmaceutical compositions comprising mesalamin and relevant excipients
CA3098604A1 (en) Dosage forms for delivery of medicines to the lower gastrointestinal tract

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230316

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230316

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240117

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240123

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240422

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20240722

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240917

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250217

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20250620